The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists Dara L. Eckerle MizeMarzieh Salehi Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) 12 March 2013 Pages: 307 - 318
Risk vs Benefit in Diabetes Pharmacotherapy: a Rational Approach to Choosing Pharmacotherapy in Type 2 Diabetes Mary Elizabeth CoxMark N. Feinglos Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) 20 March 2013 Pages: 319 - 328
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus Hanford YauKathya RiveraKenneth Cusi Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) 27 April 2013 Pages: 329 - 341
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial Markolf HanefeldPeter Bramlage Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) Open access 10 February 2013 Pages: 342 - 349
Is the Risk and Nature of CVD the Same in Type 1 and Type 2 Diabetes? Lindsey DucaRachel SipplJanet K. Snell-Bergeon Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 22 March 2013 Pages: 350 - 361
Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis Anisha A. GupteChristopher J. LyonWilla A. Hsueh Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 09 March 2013 Pages: 362 - 371
Exercise and Diabetes-Related Cardiovascular Disease: Systematic Review of Published Evidence from Observational Studies and Clinical Trials Robert W. KoivulaÅsa B. TornbergPaul W. Franks Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 14 March 2013 Pages: 372 - 380
Do Statins Cause Diabetes? Mark R. GoldsteinLuca Mascitelli Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 02 March 2013 Pages: 381 - 390
Vascular Calcification in Diabetes: Mechanisms and Implications Janet K. Snell-BergeonMatthew J. BudoffJohn E. Hokanson Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 24 March 2013 Pages: 391 - 402
Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction? Cristina BianchiRoberto MiccoliStefano Del Prato Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 03 March 2013 Pages: 403 - 410
Diabetes Mellitus and Osteoporosis Robert SealandChristie RazaviRobert A. Adler Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 08 March 2013 Pages: 411 - 418
Diabetes and HIV: Current Understanding and Future Perspectives Sanjay KalraNavneet Agrawal Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 28 February 2013 Pages: 419 - 427
Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection? Cho NaingJoon Wah MakMala Maung Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 07 March 2013 Pages: 428 - 434
Diabetes Mellitus and Inflammation Eric Lontchi-YimagouEugene SobngwiAndre Pascal Kengne Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 14 March 2013 Pages: 435 - 444
Diabetes Mellitus and Periodontal Diseases Corneliu SimaMichael Glogauer Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 21 February 2013 Pages: 445 - 452